title: Serum lipids as biomarkers for therapeutic monitoring of latent tuberculosis infection.
authors.forename: Amr S
authors.initials: AS
authors.lastname: Albanna
authors.forename: Kenneth
authors.initials: K
authors.lastname: Bachmann
authors.forename: Donald
authors.initials: D
authors.lastname: White
authors.forename: Chantal
authors.initials: C
authors.lastname: Valiquette
authors.forename: Dick
authors.initials: D
authors.lastname: Menzies
mesh_terms: D000293:Adolescent; D000328:Adult; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage; D000995:Antitubercular Agents / Q000008:administration & dosage; D001054:Apolipoproteins A / Q000378:metabolism; D001055:Apolipoproteins B / Q000378:metabolism; D015415:Biomarkers / Q000097:blood*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D055985:Latent Tuberculosis / Q000097:blood* / Q000175:diagnosis; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage; D055815:Young Adult
chemical_list: D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D015415:Biomarkers; D008055:Lipids; D007538:Isoniazid; D012293:Rifampin